Prof. John Collins This is Me

 Web References

1. 1. HarkTheHerald.com

   www.harktheherald.com/article. - [Cached]

   Published on: 3/18/2003   Last Visited: 3/18/2003

   Cosmix was founded by John Collins, an internationally renowned pioneer in the field of molecular biology, to leverage his research in identifying small proteins (peptides) that have specific applications in creating health-care products and pharmaceuticals.

2. 2. Press Releases

   www.nuskinenterprises.com/corp - [Cached]

   Published on: 3/13/2003   Last Visited: 7/22/2004

   "Cosmix has captured the essence of how nature has evolved and 'optimized' functional molecules, particularly peptides and proteins, feeding this knowledge into a powerful machinery for rapid novel product development," said John Collins, Chief Technology Officer and founder of Cosmix. "We are excited that Nu Skin shares our vision of how this can be applied to their specific needs."
   
   Professor John Collins, an internationally renowned pioneer and inventor in the field of gene technology and molecular biology founded Cosmix in 1997.

3. 3. Pharmaceutical Technology - Cosmix molecular biologicals GmbH - High Affinity Peptides

   www.pharmaceutical-technology. - [Cached]

   Published on: 7/19/2001   Last Visited: 2/24/2003

   Founded in 1997 by Professor John Collins, Cosmix is a research company with a unique, proprietary technology base that yields peptides of unparalleled affinity (nanomolar/sub-nanomolar) to identified targets, such as enzymes, and receptors. The company's pioneering work has opened the door to the use of peptides in a wide range of industrial, healthcare and research applications, previously restricted to the much larger, and more difficult to manage antibodies. Potential applications for the high affinity peptides created by Cosmix include:
   
   A new generation of small molecule therapeutics and diagnostics New and improved screening and labelling tools Novel industrial processes